Bollard Group’s Celgene Corp CELG Stock Holding History

Bollard Group’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-476	Closed	-$59K	–	283
2017 Q1	$59K	Hold	476	–	–	﹤0.01%	216
2016 Q4	$55K	Hold	476	–	–	﹤0.01%	219
2016 Q3	$50K	Hold	476	–	–	﹤0.01%	217
2016 Q2	$47K	Hold	476	–	–	﹤0.01%	209
2016 Q1	$48K	Hold	476	–	–	﹤0.01%	211
2015 Q4	$57K	Hold	476	–	–	﹤0.01%	213
2015 Q3	$51K	Hold	476	–	–	﹤0.01%	231
2015 Q2	$55K	Hold	476	–	–	﹤0.01%	229
2015 Q1	$55K	Hold	476	–	–	﹤0.01%	227
2014 Q4	$53K	Hold	476	–	–	﹤0.01%	223
2014 Q3	$45K	Hold	476	–	–	﹤0.01%	236
2014 Q2	$41K	Hold	476	–	–	﹤0.01%	235
2014 Q1	$33K	Hold	476	–	–	﹤0.01%	234
2013 Q4	$40K	Hold	476	–	–	﹤0.01%	229
2013 Q3	$37K	Buy	+476	New	+$33.4K	﹤0.01%	234

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bollard Group's CELG Position: Q2 2017 in Review

Bollard Group sold out of Celgene Corp (CELG) in Q2 2017, closing a stake of 476 shares — an estimated $59K sold.

Bollard Group first reported a position in CELG in Q3 2013 and held it in 15 quarters. The position peaked at $59K in Q1 2017. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

Bollard Group reported no remaining Celgene Corp position as of Q2 2017 after selling out during the quarter.
Bollard Group sold 476 Celgene Corp shares in Q2 2017, an estimated $59K.
Bollard Group first reported a position in Celgene Corp in Q3 2013 and held it in 15 quarters.
Bollard Group's Celgene Corp position peaked at $59K in Q1 2017.
1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Bollard Group's 13F filing for Q2 2017, filed 20 Jul 2017.